>中東およびアフリカの契約製造市場、製品別（医薬品製造および医療機器製造）、エンドユーザー別（製薬会社、バイオテクノロジー会社、バイオ医薬品会社、医療機器会社、OEM、研究機関）、流通チャネル別（小売販売、直接入札、その他） - 2030 年までの業界動向と予測。
中東およびアフリカの契約製造市場の分析と洞察
中東およびアフリカの契約製造市場は、医薬品およびパイプライン製品の技術進歩とコスト効率の向上による需要の高まり、および研究開発への投資の増加によって市場が成長するなどの要因によって推進されています。現在、先進国および新興国全体で医療費が増加しており、メーカーが新しい革新的な製品を開発するための競争上の優位性が生まれることが期待されています。
契約製造とは、企業と製造業者の間で、指定された期間内に企業のために一定数の部品または製品を製造する契約です。製造された商品は、企業のラベルまたはブランドで販売されます。これはプライベート ラベル製造と呼ばれます。国境を越えて行われる場合は、アウトソーシングとも呼ばれます。製造業者は、顧客が独自の設計、処方、仕様を提供しない限り、独自の設計、処方、仕様に基づいてサービスを提供します。製造業者は、競合企業であっても、契約した相手にこれらの製品を作成します。
契約製造市場の成長を牽引する主な要因の 1 つは、医療機器および医薬品セクターにおける世界的な需要の高まりです。いくつかの企業がより良い診断のために行っている継続的な臨床試験研究は、市場の拡大につながります。市場は、技術の進歩とコスト効率の向上にも影響されます。ただし、機密情報のリスクと厳格な規制は、予測期間中に中東およびアフリカの契約製造市場の抑制要因として機能する可能性があります。
一方、特許の期限切れやジェネリック医薬品の需要増加、医療インフラの費用増加、主要市場プレーヤーによる戦略的取り組みは、市場の成長の機会となります。しかし、知的財産リスクや独自の製造ユニットを設立する製薬会社の増加は、中東およびアフリカの契約製造市場に課題をもたらす可能性があります。
ポイントオブケア診断への傾向の高まりにより、受託製造の需要は世界的に増加するでしょう。さまざまな企業が徐々に市場の成長につながる取り組みを行っています。
The Middle East and Africa contract manufacturing market is supportive and aims to reduce the manufacturing efforts of the healthcare organizations. Data Bridge Market Research analyses that Middle East and Africa Contract Manufacturing market will grow at a CAGR of 5.3% during the forecast period of 2023 to 2030.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015- 2020) |
|
Quantitative Units |
Revenue in USD Million, Pricing in USD |
|
Segments Covered |
By Product (Pharmaceutical Products Manufacturing and Medical Device Manufacturing), By End User (Pharmaceutical Companies, Biotechnology Companies, Biopharma Companies, Medical Device Companies, Original Equipment Manufacturer, and Research Institutes), By Distribution Channel (Retail Sales, Direct Tender, and Others) |
|
Countries Covered |
Saudi Arabia, South Africa, U.A.E, Israel, Kuwait, Egypt, and the Rest of the Middle East and Africa |
|
Market Players Covered |
Aenova Group, Thermo Fisher Scientific Inc., EVONIK INDUSTRIES AG, Lonza, Boehringer Ingelheim Biopharmaceuticals GmbH., and Catalent, Inc among others |
Middle East and Africa Contract Manufacturing Dynamics
Market Definition
Contract manufacturing in international markets is used in situations when one company arranges for another company in a different country to manufacture its products; this is also known as international subcontracting or international outsourcing. The company provides the manufacturer with all the specifications, and, if applicable, also with the materials required for the production process. This type of contract sets out the requirements, which the manufacturer must meet concerning the quality of the products, certification, quantities, conditions and dates of delivery, etc. It also establishes guidelines for the inspection and testing of the products set forth by the company which contracts out the manufacture, or by its own clients. Furthermore, it also outlines modifications to orders, as well as guarantees and compensation in case of breach of contract. Since the process is essentially outsourcing production in foreign markets to a partner that privately brands the end product, there are a number of different companies and industries that can make use of this type of contract.
Drivers
- Cost-effectiveness for the manufacturing companies
The time-consuming manufacturing and ineffective production for several things and management are major burdens for public and private sector organizations. They are also essential for addressing complex challenges because a single organization is less effective in driving the change and sometimes required outcomes. The contract manufacturing companies will act as rising opportunities for both governmental and private sectors
The rising demand for contract manufacturing with improved accuracy and less time constraint pushes the key players for strategic initiatives. Owning contract manufacturing frees up the overhead charges required to invest in machinery, material, and another workforce, simplifying the production process and streamlining the supply chain by reducing the overall cost.
However, major market players are investing heavy capital in manufacturing to reach the demands of their end users. The contract manufacturing players are involved in making the strategies and implementing them by reducing the cost of production of these players. Contract manufacturing services to other firms also ensure efficiency and optimum usage of resources by using effective workforce, strategic intelligence, or working resources required in the production cycle.
- Rise of technological advancements in contract manufacturing
Introducing a new drug in the market promptly requires considerable investments in manufacturing due to the escalated demand in the pharmaceutical industry. Advanced technologies and skills are mandatory as some drugs have complex formulas and require specific equipment and techniques when mass-produced.
The usage of innovative technologies such as machine learning, big data, and artificial intelligence to develop pharmaceutical drugs or manufacture medical devices are being considered for rapid and quick manufacturing. These technical advancements also help in mass production and scalability in a short span of time.
However, pharmaceutical firms conventionally audit or supervise their contract manufacturing organization's production and delivery processes to monitor the manufacturing process using real-time remote tracing.
Opportunities
- Growing expenses on the development of healthcare infrastructure
Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population. Infrastructure must integrate the hospital, as the center for acute and inpatient care, into the broader healthcare system and should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements: equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff.
However, the growing expenses on the development of healthcare infrastructure are propelling the growth of the Middle East and Africa contract manufacturing market in the forecast period.
Restraints/Challenges
- Increase in the Number of Pharmaceutical Companies Set Up Their Manufacturing Sites
製薬会社の多くは、コスト削減のため医薬品を生産する製造拠点を建設しています。製造業者は、高度な技術とデジタル化プロセスの導入に注力しています。製薬業界は、新しいビジネス モデルや、パーソナライズされた医薬品や治療に重点を置く人々による混乱にも直面しています。そのため、パーソナライズされたケアの需要は高まっています。職業プロファイルも変化しています。自動化により一部の職業が消滅する一方で、まったく新しい職業が生まれています。
したがって、製造ユニットを設立する製薬会社の数の増加は、予測期間中の中東およびアフリカの契約製造市場の成長に影響を与える可能性があります。
最近の動向
- ベーリンガーインゲルハイムインターナショナルは2021年10月、オーストリアのウィーンに最先端のバイオ医薬品生産施設である大規模細胞培養（LSCC）を開設しました。投資額は7億ユーロを超え、これは同社史上最大の投資です。
- エボニック インダストリーズ AG は、2023 年 3 月に、高度な医薬品薬物送達アプリケーション向けの脂質を製造するための新しい GMP 施設を開設すると発表しました。脂質発売施設はドイツのハーナウにある同社の敷地内にあり、臨床および小規模商業製造に必要な量の脂質を顧客に提供します。
中東およびアフリカの契約製造市場のセグメンテーション
中東およびアフリカの契約製造市場は、製品、エンドユーザー、流通チャネルに基づいて 3 つの主要なセグメントに分類されます。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コア アプリケーション領域とターゲット市場の違いを判断するのに役立ちます。
製品
- 医療機器製造
- 医薬品製造
製品に基づいて、中東およびアフリカの契約製造市場は、医療機器製造と医薬品製造に分類されます。
エンドユーザー
- 製薬会社
- バイオテクノロジー企業
- バイオ医薬品企業
- 医療機器企業
- オリジナル機器メーカー
- 研究機関
エンドユーザーに基づいて、中東およびアフリカの契約製造市場は、OEM、医療機器会社、製薬会社、バイオテクノロジー会社、バイオ医薬品会社、および研究機関に分類されます。
流通チャネル
- 小売販売
- 直接入札
- その他
流通チャネルに基づいて、中東およびアフリカの契約製造市場は、直接入札、小売販売、その他に分類されます。
中東およびアフリカの契約製造市場の地域分析/洞察
中東およびアフリカの契約製造市場が分析され、上記のように製品、エンドユーザー、流通チャネル別に市場規模の洞察と傾向が提供されます。
契約製造レポートで取り上げられている国には、サウジアラビア、南アフリカ、UAE、イスラエル、クウェート、エジプト、その他の中東およびアフリカ諸国などがあります。
発展途上地域での技術進歩の進展により、南アフリカが優位に立つことが予想されます。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、個々の国の市場シナリオを予測するために使用される指標の一部です。また、中東およびアフリカのブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、国内関税と貿易ルートの影響を考慮しながら、国別データの予測分析を提供します。
競争環境と中東およびアフリカの契約製造市場シェア分析
中東およびアフリカの契約製造市場の競争状況は、競合他社の詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、中東およびアフリカでのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、中東およびアフリカの契約製造市場に対する会社の重点にのみ関連しています。
この市場のプレーヤーとしては、Aenova Group、Thermo Fisher Scientific Inc.、EVONIK INDUSTRIES AG、Lonza、Boehringer Ingelheim Biopharmaceuticals GmbH、Catalent, Inc などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 STRATEGIC INITIATIVES:
5 REGULATORY FRAMEWORK
5.1 REGULATORY SCENARIO BY FDA
5.2 REGULATORY SCENARIO IN AUSTRALIA
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING
6.1.3 MIDDLE EAST & AFRICA PRESENCE AND CONNECTED NETWORK
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS
6.2.2 RISK OF CONFIDENTIAL INFORMATION
6.3 OPPORTUNITIES
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.4 CHALLENGES
6.4.1 INTELLECTUAL PROPERTY RISKS
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES
7 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING
7.2.1 TYPES OF PRODUCTS
7.2.1.1 TABLETS
7.2.1.2 CAPSULES
7.2.1.3 BIOLOGICS
7.2.1.4 SMALL MOLECULE
7.2.1.5 CELL & GENES MANUFACTURING
7.2.1.6 NUTRACEUTICALS
7.2.1.7 OTHERS
7.2.2 TYPE OF SERVICES
7.2.2.1 DRUG DEVELOPMENT SERVICES
7.2.2.2 TABLET MANUFACTURING SERVICES
7.2.2.3 BIOLOGICS API MANUFACTURING
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES
7.2.2.5 OTHERS
7.2.3 BY DOSAGE FORM
7.2.3.1 SOLID FORMULATIONS
7.2.3.2 LIQUID FORMULATIONS
7.2.3.2.1 INJECTABLE
7.2.3.2.2 SYRUPS
7.2.3.3 SEMI-SOLID FORMULATIONS
7.2.3.4 TOPICAL DRUG FORMULATIONS
7.2.3.5 OTHERS
7.3 MEDICAL DEVICE MANUFACTURING
7.3.1 TYPE OF DEVICES
7.3.1.1 SYRINGES AND NEEDLES
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES
7.3.1.4 DISPOSABLES
7.3.1.5 IVD DEVICES
7.3.1.6 CARDIOVASCULAR DEVICES
7.3.1.7 DIABETES CARE DEVICES
7.3.1.8 GENERAL SURGERY DEVICES
7.3.1.9 ORTHOPEDIC DEVICES
7.3.1.10 RESPIRATORY DEVICES
7.3.1.11 OPHTHALMIC DEVICES
7.3.1.12 DENTAL DEVICES
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES
7.3.1.14 LABORATORY EQUIPMENT
7.3.2 TYPE OF SERVICES
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT
7.3.2.2 DEVICE ASSEMBLY
7.3.2.3 REGULATORY ASSISTANCE
7.3.2.4 PACKAGING & LABELLING
7.3.2.5 STERILIZATION SERVICES
7.3.2.6 TRAINING AND VALIDATION
7.3.2.7 QUALITY ASSURANCE
7.3.2.8 OTHERS
7.3.3 BY DEVICE CLASS
7.3.3.1 CLASS I MEDICAL DEVICES
7.3.3.2 CLASS IIA MEDICAL DEVICES
7.3.3.3 CLASS IIB MEDICAL DEVICES
7.3.3.4 CLASS III MEDICAL DEVICES
8 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY END USER
8.1 OVERVIEW
8.2 PHARMACEUTICAL COMPANIES
8.3 BIOTECHNOLOGY COMPANIES
8.4 BIOPHARMA COMPANIES
8.5 MEDICAL DEVICES COMPANIES
8.6 ORIGINAL EQUIPMENT MANUFACTURER
8.7 RESEARCH INSTITUTES
9 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 RETAIL SALES
9.3 DIRECT TENDER
9.4 OTHERS
10 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY REGION
10.1 MIDDLE EAST AND AFRICA
10.1.1 SOUTH AFRICA
10.1.2 SAUDI ARABIA
10.1.3 U.A.E.
10.1.4 EGYPT
10.1.5 ISRAEL
10.1.6 REST OF MIDDLE EAST AND AFRICA
11 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
12 SWOT ANALYSIS
13 COMPANY PROFILE
13.1 AENOVA GROUP
13.1.1 COMPANY SNAPSHOT
13.1.2 COMPANY SHARE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 EVONIK INDUSTRIES AG
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 LONZA
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 ABBVIE INC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 ALMAC GROUP
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 AVID BIOSERVICES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 BAXTER
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.1 CATALENT, INC
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 FAMAR HEALTH CARE SERVICES
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENTS
13.12 JUBILANT PHARMA LIMITED
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 KIMBALL INTERNATIONAL
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 MERCK KGAA
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 NIPR0
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 PFIZER INC
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENT
13.17 RECIPHARM AB.
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENT
13.18 SIEGFRIED HOLDING AG
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENT
13.2 TE CONNECTIVITY
13.20.1 COMPANY SNAPSHOT
13.20.2 REVENUE ANALYSIS
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENT
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表のリスト
TABLE 1 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, 2021-2030, 2021-2030 (UNIT)
TABLE 29 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP
TABLE 30 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 32 MIDDLE EAST AND AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 36 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 37 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 SOUTH AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 44 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 45 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 46 SOUTH AFRICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 47 SOUTH AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 SOUTH AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 SOUTH AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 52 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 53 SOUTH AFRICA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 SOUTH AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 56 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 57 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 58 SAUDI ARABIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 59 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 61 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 62 SAUDI ARABIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 SAUDI ARABIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 SAUDI ARABIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 SAUDI ARABIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 68 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 69 SAUDI ARABIA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 70 SAUDI ARABIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 72 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 73 UA.E. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 74 UA.E. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 76 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 77 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 78 UA.E. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 UA.E. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 UA.E. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 UA.E. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 84 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 85 UA.E. TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 86 UA.E. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 87 UA.E. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 UA.E. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 89 EGYPT CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 90 EGYPT PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 91 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 93 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 94 EGYPT BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 95 EGYPT BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 EGYPT LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 EGYPT MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 99 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 100 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 101 EGYPT TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 102 EGYPT BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 EGYPT CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 104 EGYPT CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 105 ISRAEL CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 106 ISRAEL PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 108 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 109 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 110 ISRAEL BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 ISRAEL BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 112 ISRAEL LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 113 ISRAEL MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 114 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 116 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 117 ISRAEL TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 118 ISRAEL BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 119 ISRAEL CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 ISRAEL CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 121 REST OF MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
図表一覧
FIGURE 1 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 RISING TECHNOLOGICAL ADVANCEMENTS AND COST-EFFECTIVENESS OF PHARMACEUTICAL AND MEDICAL PRODUCTS ARE EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET
FIGURE 12 THE PHARMACEUTICAL PRODUCTS MANUFACTURING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET IN 2023 & 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR CONTRACT MANUFACTURING MARKET MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET
FIGURE 16 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2022
FIGURE 17 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 19 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, 2022
FIGURE 21 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 23 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 25 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 27 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: SNAPSHOT (2022)
FIGURE 29 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022)
FIGURE 30 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 31 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 32 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
